Increased tissue transglutaminase expression in human atherosclerotic coronary arteries.
D045744:Cell Line, Tumor; D003324:Coronary Artery Disease / Q000201:enzymology* / Q000473:pathology; D003331:Coronary Vessels / Q000201:enzymology* / Q000473:pathology; D051546:Cyclooxygenase 2 / Q000378:metabolism; D019204:GTP-Binding Proteins; D006801:Humans; D032389:Myocytes, Smooth Muscle / Q000201:enzymology; D016328:NF-kappa B / Q000378:metabolism; D000091345:Protein Glutamine gamma Glutamyltransferase 2; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism; D015398:Signal Transduction; D014162:Transfection; D011503:Transglutaminases / Q000235:genetics / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D015854:Up-Regulation
D016328:NF-kappa B; D034741:RNA, Small Interfering; D014409:Tumor Necrosis Factor-alpha; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D000091345:Protein Glutamine gamma Glutamyltransferase 2; D011503:Transglutaminases; D019204:GTP-Binding Proteins